Nataliia V. Bocharova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nataliia V. Bocharova has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Tatyana P. Novgorodtseva
Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Medical Climatology and Rehabilitative Treatment
7 shared publications - I. S. Kovalenko
Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Medical Climatology and Rehabilitative Treatment
4 shared publications - Yuliya K. Denisenko
Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Medical Climatology and Rehabilitative Treatment
4 shared publications - Tatyana Isaakovna Vitkina
Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Institute of Medical Climatology and Rehabilitative Treatment
3 shared publications - Oksana Yu. Kytikova
Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Medical Climatology and Rehabilitative Treatment
2 shared publications - Ekaterina V. Ermolenko
A.V. Zhirmunsky National Scientific Center of Marine Biology, Far Eastern Branch, Russian Academy of Sciences, ul. Palchevskogo 17, 690041 Vladivostok, Russia
1 shared publication
Latest Publications
- 1 March 2026
- Published by Pleiades Publishing Ltd in Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry
- Vol. 20 (1) , 31-40
Regulation of Fatty Acid Composition of Leukocytes by Exogenous N-Eicosapentaenoylethanolamine in Asthma
- 1 March 2026
- Published by Pleiades Publishing Ltd in Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry
- Vol. 20 (1) , 31-40
Regulation of Fatty Acid Composition of Leukocytes by Exogenous N-Eicosapentaenoylethanolamine in Asthma
- Open Access
- 27 December 2024
- Published by Far Eastern Scientific Center Of Physiology and Pathology of Respiration in Bulletin physiology and pathology of respiration
- No. 94,p. 104-110
Features of interaction between selective lipid metabolites and immune system signaling molecules in patients with asthma
Introduction. Lipid metabolism is a key component in many pathophysiological processes, and its disruption can play a significant role in the development of chronic inflammation in asthma. Aim. To determine the nature of the interaction between fatty acids (FAs) and their derivatives with cytokine parameters of the immune system and their contribution to systemic inflammation in patients with asthma. Materials and methods. The spectrum of FAs in the plasma of patients with asthma was analyzed using gas chromatography-mass spectrometry. Levels of endogenous fatty acid ethanolamides (NAEs) were measured using high-performance liquid chromatography with mass spectrometry. Cytokine levels were determined by enzyme-linked immunosorbent assay (ELISA). The degree of interaction between the parameters was assessed using systemic analysis based on the integral coupling index (D). Results. It was established that the immune system response was most strongly associated with the relative content of n-6 polyunsaturated fatty acids. Modification of the FA composition was most significantly linked with interleukins (IL) 17A, 10, 4, and 6. Endogenous NAEs—arachidonoylethanolamide (AEA, 20:4n6) and docosahexaenoylethanolamide (DHEA, 22:6n3)—showed significant involvement in cytokine regulation in mild asthma. NAE 20:4n6 had the strongest association with IL-17A, interferon-γ, tumor necrosis factor (TNF)-α, and IL-2; NAE 22:6n3 was associated with IL-17A, IL-6, and TNF-α. Conclusion. The study established the contribution of disturbances in trigger parameters of lipid metabolism to systemic inflammation. Modification of FA composition and disruption of the synthesis of their mediators lead to dysregulation of the cytokine network of the immune system, which may contribute to the development and chronicity of systemic inflammatory reactions in patients with asthma.
- 27 December 2024
- Published by Far Eastern Scientific Center Of Physiology and Pathology of Respiration in Bulletin physiology and pathology of respiration
- No. 94,p. 104-110
Open AccessFeatures of interaction between selective lipid metabolites and immune system signaling molecules in patients with asthma
Introduction. Lipid metabolism is a key component in many pathophysiological processes, and its disruption can play a significant role in the development of chronic inflammation in asthma. Aim. To determine the nature of the interaction between fatty acids (FAs) and their derivatives with cytokine parameters of the immune system and their contribution to systemic inflammation in patients with asthma. Materials and methods. The spectrum of FAs in the plasma of patients with asthma was analyzed using gas chromatography-mass spectrometry. Levels of endogenous fatty acid ethanolamides (NAEs) were measured using high-performance liquid chromatography with mass spectrometry. Cytokine levels were determined by enzyme-linked immunosorbent assay (ELISA). The degree of interaction between the parameters was assessed using systemic analysis based on the integral coupling index (D). Results. It was established that the immune system response was most strongly associated with the relative content of n-6 polyunsaturated fatty acids. Modification of the FA composition was most significantly linked with interleukins (IL) 17A, 10, 4, and 6. Endogenous NAEs—arachidonoylethanolamide (AEA, 20:4n6) and docosahexaenoylethanolamide (DHEA, 22:6n3)—showed significant involvement in cytokine regulation in mild asthma. NAE 20:4n6 had the strongest association with IL-17A, interferon-γ, tumor necrosis factor (TNF)-α, and IL-2; NAE 22:6n3 was associated with IL-17A, IL-6, and TNF-α. Conclusion. The study established the contribution of disturbances in trigger parameters of lipid metabolism to systemic inflammation. Modification of FA composition and disruption of the synthesis of their mediators lead to dysregulation of the cytokine network of the immune system, which may contribute to the development and chronicity of systemic inflammatory reactions in patients with asthma.
- Open Access
- 22 March 2024
- Published by Far Eastern Scientific Center Of Physiology and Pathology of Respiration in Bulletin physiology and pathology of respiration
- No. 91,p. 59-67
The effect of N-eicosapentaenoyl ethanolamine on the regulation of cytokine synthesis by blood cells of patients with bronchial asthma in vitro
Introduction. Bronchial asthma is characterized by heterogeneity, multiple phenotypes, and varying clinical manifestations. Cytokines play a crucial role in the inflammatory response in asthma. The quantity, as well as the ratio of certain cytokines, determines the mechanism and type of inflammatory response in asthma, upon which the effectiveness of treatment of this disease depends. That is why the development of new methods of treating patients with asthma, aimed at correcting cytokine imbalance, is required. One of the promising substances is N-eicosapentaenoyl-ethanolamine (NAE-EPA), which exhibits anti-inflammatory properties by affecting cytokines, but remains poorly studied.Aim. To study the dose-dependent effect of N-eicosapentaenoyl-ethanolamine on the production of cytokines by peripheral blood cells, in vitro, in subjects with asthma.Materials and methods. The object of the study was whole blood, diluted 1:5 with culture medium of 15 patients with mild to moderate controlled asthma and 16 healthy subjects. The in vitro experiment was carried out in lipopolysaccharide-stimulated (LPS) blood samples (incubation with LPS at 37°C for 30 minutes). Then, the experimental substance N-acylethanolamine eicosapentaenoic acid (NAE EPA) was added in concentrations of 1.0; 5.0, and 10.0 µM and incubated at 37°C for 6 hours with gentle mixing. Cytokine levels (IL-2, IL-4, IL-6, IL-10, IL17A, TNF-α, and INF-γ) were studied by enzyme-linked immunoassay.Results. Analysis of the level of cytokines in patients with asthma showed that an increase in the plasma levels of IL-2, TNF-α, IL-6, and IL-17A is accompanied by a decrease in the level of regulatory IL-10. When NAE EPA was added at a dosage of 1 µM, no statistically significant changes were detected. Exposure to the experimental substance at a dose of 5 µM contributed to a decrease in IL-6 in the blood cells of patients by 19% (p ˂ 0.05). Exposure to NAE EPA at 10 µM produced the greatest number of statistically significant changes in cytokine levels. There was a decrease in IL-17A by 15% (p ˂ 0.05), IL-2 by 14% (p ˂ 0.05), IL-6 by 50% (p ˂ 0.01), and TNF-α by 10% (p ˂ 0.05) relative to values before exposure.Conclusion. N-eicosapentaenoyl ethanolamine shows potential as a regulator of pro- and anti-inflammatory cytokine synthesis in bronchial asthma with a predominant Th-17 type of immune response. The results obtained may contribute to the development of new treatment strategies for patients with asthma.
- 22 March 2024
- Published by Far Eastern Scientific Center Of Physiology and Pathology of Respiration in Bulletin physiology and pathology of respiration
- No. 91,p. 59-67
Open AccessThe effect of N-eicosapentaenoyl ethanolamine on the regulation of cytokine synthesis by blood cells of patients with bronchial asthma in vitro
Introduction. Bronchial asthma is characterized by heterogeneity, multiple phenotypes, and varying clinical manifestations. Cytokines play a crucial role in the inflammatory response in asthma. The quantity, as well as the ratio of certain cytokines, determines the mechanism and type of inflammatory response in asthma, upon which the effectiveness of treatment of this disease depends. That is why the development of new methods of treating patients with asthma, aimed at correcting cytokine imbalance, is required. One of the promising substances is N-eicosapentaenoyl-ethanolamine (NAE-EPA), which exhibits anti-inflammatory properties by affecting cytokines, but remains poorly studied.Aim. To study the dose-dependent effect of N-eicosapentaenoyl-ethanolamine on the production of cytokines by peripheral blood cells, in vitro, in subjects with asthma.Materials and methods. The object of the study was whole blood, diluted 1:5 with culture medium of 15 patients with mild to moderate controlled asthma and 16 healthy subjects. The in vitro experiment was carried out in lipopolysaccharide-stimulated (LPS) blood samples (incubation with LPS at 37°C for 30 minutes). Then, the experimental substance N-acylethanolamine eicosapentaenoic acid (NAE EPA) was added in concentrations of 1.0; 5.0, and 10.0 µM and incubated at 37°C for 6 hours with gentle mixing. Cytokine levels (IL-2, IL-4, IL-6, IL-10, IL17A, TNF-α, and INF-γ) were studied by enzyme-linked immunoassay.Results. Analysis of the level of cytokines in patients with asthma showed that an increase in the plasma levels of IL-2, TNF-α, IL-6, and IL-17A is accompanied by a decrease in the level of regulatory IL-10. When NAE EPA was added at a dosage of 1 µM, no statistically significant changes were detected. Exposure to the experimental substance at a dose of 5 µM contributed to a decrease in IL-6 in the blood cells of patients by 19% (p ˂ 0.05). Exposure to NAE EPA at 10 µM produced the greatest number of statistically significant changes in cytokine levels. There was a decrease in IL-17A by 15% (p ˂ 0.05), IL-2 by 14% (p ˂ 0.05), IL-6 by 50% (p ˂ 0.01), and TNF-α by 10% (p ˂ 0.05) relative to values before exposure.Conclusion. N-eicosapentaenoyl ethanolamine shows potential as a regulator of pro- and anti-inflammatory cytokine synthesis in bronchial asthma with a predominant Th-17 type of immune response. The results obtained may contribute to the development of new treatment strategies for patients with asthma.
- Open Access
- 28 September 2023
- Published by Far Eastern Scientific Center Of Physiology and Pathology of Respiration in Bulletin physiology and pathology of respiration
- No. 89,p. 18-24
Dose-dependent effect of ethanolamine of eicosapentaenoic acid on the synthesis of oxylipins by blood cells of patients with bronchial asthma in vitro
Introduction. The search for new highly effective methods for the treatment and control of bronchial asthma is an urgent task in pathophysiology and pharmacology. A promising substance for the regulation of systemic chronic inflammation is N-acylethanolamine (EPEA) of eicosapentaenoic acid, which exhibits immunoregulatory properties.Aim. To study the dose-dependent effect of eicosapentaenoic acid ethanolamine on the synthesis and metabolism of oxylipins by blood cells in patients with asthma under in vitro conditions.Materials and methods. The object of the study was the whole blood of 5 patients with controlled mild-to-moderate asthma and 6 healthy people. The in vitro experiment was carried out in lipopolysaccharide-stimulated blood after incubation for 30 minutes. Then the experimental substance N-acyl-ethanolamine of eicosapentaenoic acid (NAE 20:5) was added at concentrations of 1.0, 5.0 and 10.0 µM and incubated at 37ºC for 6 hours in gentle mixing mode. The level of oxylipins was studied by enzyme immunoassay.Results. Experimental exposure to N-acylethanolamines of eicosapentenoic acid had the following effects. Under the influence of ethanolamine of eicosapentaenoic acid at a concentration of 1 µM, the level of PGE2 decreased by 51% (pConclusion. Further study of NAE fatty acids opens up new perspectives in the study of targeted methods for correcting the inflammatory response in bronchial asthma.
- 28 September 2023
- Published by Far Eastern Scientific Center Of Physiology and Pathology of Respiration in Bulletin physiology and pathology of respiration
- No. 89,p. 18-24
Open AccessDose-dependent effect of ethanolamine of eicosapentaenoic acid on the synthesis of oxylipins by blood cells of patients with bronchial asthma in vitro
Introduction. The search for new highly effective methods for the treatment and control of bronchial asthma is an urgent task in pathophysiology and pharmacology. A promising substance for the regulation of systemic chronic inflammation is N-acylethanolamine (EPEA) of eicosapentaenoic acid, which exhibits immunoregulatory properties.Aim. To study the dose-dependent effect of eicosapentaenoic acid ethanolamine on the synthesis and metabolism of oxylipins by blood cells in patients with asthma under in vitro conditions.Materials and methods. The object of the study was the whole blood of 5 patients with controlled mild-to-moderate asthma and 6 healthy people. The in vitro experiment was carried out in lipopolysaccharide-stimulated blood after incubation for 30 minutes. Then the experimental substance N-acyl-ethanolamine of eicosapentaenoic acid (NAE 20:5) was added at concentrations of 1.0, 5.0 and 10.0 µM and incubated at 37ºC for 6 hours in gentle mixing mode. The level of oxylipins was studied by enzyme immunoassay.Results. Experimental exposure to N-acylethanolamines of eicosapentenoic acid had the following effects. Under the influence of ethanolamine of eicosapentaenoic acid at a concentration of 1 µM, the level of PGE2 decreased by 51% (pConclusion. Further study of NAE fatty acids opens up new perspectives in the study of targeted methods for correcting the inflammatory response in bronchial asthma.
- Open Access
- 23 December 2022
- Published by Far Eastern Scientific Center Of Physiology and Pathology of Respiration in Bulletin physiology and pathology of respiration
- Vol. 1 (86) , 129-137
Prospects for the pharmacological application of N-acyle-thanolamines of polyunsaturated fatty acids in the therapy of respiratory diseases on the example of bronchial asthma
Introduction. At present, the mechanisms of the processes of resolving chronic inflammation in asthma are not fully understood. A search for new pharmacological preparations and substances for the treatment and control of the course of asthma is required. Promising in this direction are N-acylethanolamines (NAE) of polyunsaturated fatty acids - bioactive lipid molecules that exhibit many signaling functions. NAEs are capable of influencing the synthesis of pro-inflammatory cytokines and are also appear to be a substrate for the synthesis of pro-permissive lipid signaling molecules. This review collects data on NAE, provides an overview, biosynthesis, and describes their anti-inflammatory effects.Aim. Summarizing the data of domestic and foreign researchers on the possibility of NAE in the treatment of respiratory diseases on the example of bronchial asthma.Materials and methods. The review uses data from articles published in PubMed, Google Scholar, eLIBRARY.Results. The study and compilation of literature on this issue made it possible to conclude that synthetic NAEs are promising pharmacological objects for asthma therapy, however, further testing of the anti-inflammatory effects of NAEs and the establishment of the molecular mechanism of their action on inflammation processes are needed.
- 23 December 2022
- Published by Far Eastern Scientific Center Of Physiology and Pathology of Respiration in Bulletin physiology and pathology of respiration
- Vol. 1 (86) , 129-137
Open AccessProspects for the pharmacological application of N-acyle-thanolamines of polyunsaturated fatty acids in the therapy of respiratory diseases on the example of bronchial asthma
Introduction. At present, the mechanisms of the processes of resolving chronic inflammation in asthma are not fully understood. A search for new pharmacological preparations and substances for the treatment and control of the course of asthma is required. Promising in this direction are N-acylethanolamines (NAE) of polyunsaturated fatty acids - bioactive lipid molecules that exhibit many signaling functions. NAEs are capable of influencing the synthesis of pro-inflammatory cytokines and are also appear to be a substrate for the synthesis of pro-permissive lipid signaling molecules. This review collects data on NAE, provides an overview, biosynthesis, and describes their anti-inflammatory effects.Aim. Summarizing the data of domestic and foreign researchers on the possibility of NAE in the treatment of respiratory diseases on the example of bronchial asthma.Materials and methods. The review uses data from articles published in PubMed, Google Scholar, eLIBRARY.Results. The study and compilation of literature on this issue made it possible to conclude that synthetic NAEs are promising pharmacological objects for asthma therapy, however, further testing of the anti-inflammatory effects of NAEs and the establishment of the molecular mechanism of their action on inflammation processes are needed.
- 20 December 2022
- Published by LLC Science and Innovations in Russian Open Medical Journal
- Vol. 11 (4)
Associations Of Fatty Acid Composition In Leukocyte Membranes With Systemic Inflammation In Chronic Obstructive Pulmonary Disease Progression
Background — The development of systemic inflammation is a key pathogenetic mechanism in progression of chronic obstructive pulmonary disease (COPD). Fatty acids (FAs) and their oxidized derivatives serve as essential regulators of inflammation. The relationship between systemic inflammation and FA metabolism in COPD is poorly understood. In our research, we focused on examining the FA composition of the leukocyte membrane in COPD and the FA metabolism in association with systemic inflammation. Objective — We examined 137 patients with mild, moderate, or severe COPD. The control group comprised 32 healthy non-smokers. Methods — Blood cytokines and immune cell subpopulations were evaluated by flow cytometry. The FA composition of the leukocyte membranes was analyzed by gas chromatography. The concentrations of eicosanoids (thromboxane B2 (TXB2), leukotriene B4 (LTB4)) in plasma were measured by ELISA. Results — Our results implied systemic inflammation in all patients with COPD. The analysis of the FA composition of leukocyte membrane demonstrated increased level of saturated FAs and n-6 polyunsaturated fatty acids (PUFAs), along with reduced levels of monounsaturated FAs and n-3 PUFAs, in patients with COPD. The TXB2 and LTB4 content was increasing in COPD patients. We established a significant correlation with n-6 PUFAs, immune cells, and cytokines, which was indicative of an important role of FAs in the progress of systemic inflammation in COPD. Conclusion — Thus, FA modification of immune cells in patients with chronic pathologies of the bronchopulmonary system leads not only to disruption of the cell membrane structure, but also to the pathology of immune response regulation, and contributes to the development of the inflammatory process. The latter is a decisive factor in the pathogenesis of COPD.
- 20 December 2022
- Published by LLC Science and Innovations in Russian Open Medical Journal
- Vol. 11 (4)
Associations Of Fatty Acid Composition In Leukocyte Membranes With Systemic Inflammation In Chronic Obstructive Pulmonary Disease Progression
Background — The development of systemic inflammation is a key pathogenetic mechanism in progression of chronic obstructive pulmonary disease (COPD). Fatty acids (FAs) and their oxidized derivatives serve as essential regulators of inflammation. The relationship between systemic inflammation and FA metabolism in COPD is poorly understood. In our research, we focused on examining the FA composition of the leukocyte membrane in COPD and the FA metabolism in association with systemic inflammation. Objective — We examined 137 patients with mild, moderate, or severe COPD. The control group comprised 32 healthy non-smokers. Methods — Blood cytokines and immune cell subpopulations were evaluated by flow cytometry. The FA composition of the leukocyte membranes was analyzed by gas chromatography. The concentrations of eicosanoids (thromboxane B2 (TXB2), leukotriene B4 (LTB4)) in plasma were measured by ELISA. Results — Our results implied systemic inflammation in all patients with COPD. The analysis of the FA composition of leukocyte membrane demonstrated increased level of saturated FAs and n-6 polyunsaturated fatty acids (PUFAs), along with reduced levels of monounsaturated FAs and n-3 PUFAs, in patients with COPD. The TXB2 and LTB4 content was increasing in COPD patients. We established a significant correlation with n-6 PUFAs, immune cells, and cytokines, which was indicative of an important role of FAs in the progress of systemic inflammation in COPD. Conclusion — Thus, FA modification of immune cells in patients with chronic pathologies of the bronchopulmonary system leads not only to disruption of the cell membrane structure, but also to the pathology of immune response regulation, and contributes to the development of the inflammatory process. The latter is a decisive factor in the pathogenesis of COPD.
- 1 June 2022
- Published by Institute of Biochemistry in Biomeditsinskaya Khimiya
- Vol. 68 (3) , 177-189
Fatty acid epoxides in the regulation of the inflammation
Cyclooxygenase and lipoxygenase derived lipid metabolites of polyunsaturated fatty acids (PUFAs), as well as their role in the inflammation, have been studied quite thoroughly. However, cytochrome P450 derived lipid mediators, as well as their participation in the regulation of the inflammation, need deeper understanding. In recent years, it has become known that PUFAs are oxidized by cytochrome P450 epoxygenases to epoxy fatty acids, which act as the extremely powerful lipid mediators involved in resolving inflammation. Recent studies have shown that the anti-inflammatory mechanisms of ω-3 PUFAs are also mediated by their conversion to the endocannabinoid epoxides. Thus, it is clear that a number of therapeutically relevant functions of PUFAs are due to their conversion to PUFA epoxides. However, with the participation of cytochrome P450 epoxygenases, not only PUFA epoxides, but also other metabolites are formed. They are further are converted by epoxide hydrolases into pro-inflammatory dihydroxy fatty acids and anti-inflammatory dihydroxyeicosatrienoic acids. The study of the role of PUFA epoxides in the regulation of the inflammation and pharmacological modeling of the activity of epoxide hydrolases are the promising strategies for the treatment of the inflammatory diseases. This review systematizes the current literature data of the fatty acid epoxides, in particular, the endocannabinoid epoxides. Their role in the regulation of inflammation is discussed.
- 1 June 2022
- Published by Institute of Biochemistry in Biomeditsinskaya Khimiya
- Vol. 68 (3) , 177-189
Fatty acid epoxides in the regulation of the inflammation
Cyclooxygenase and lipoxygenase derived lipid metabolites of polyunsaturated fatty acids (PUFAs), as well as their role in the inflammation, have been studied quite thoroughly. However, cytochrome P450 derived lipid mediators, as well as their participation in the regulation of the inflammation, need deeper understanding. In recent years, it has become known that PUFAs are oxidized by cytochrome P450 epoxygenases to epoxy fatty acids, which act as the extremely powerful lipid mediators involved in resolving inflammation. Recent studies have shown that the anti-inflammatory mechanisms of ω-3 PUFAs are also mediated by their conversion to the endocannabinoid epoxides. Thus, it is clear that a number of therapeutically relevant functions of PUFAs are due to their conversion to PUFA epoxides. However, with the participation of cytochrome P450 epoxygenases, not only PUFA epoxides, but also other metabolites are formed. They are further are converted by epoxide hydrolases into pro-inflammatory dihydroxy fatty acids and anti-inflammatory dihydroxyeicosatrienoic acids. The study of the role of PUFA epoxides in the regulation of the inflammation and pharmacological modeling of the activity of epoxide hydrolases are the promising strategies for the treatment of the inflammatory diseases. This review systematizes the current literature data of the fatty acid epoxides, in particular, the endocannabinoid epoxides. Their role in the regulation of inflammation is discussed.
- Open Access
- 26 September 2018
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 96 (4)
The fatty acid composition of the mitochondrial membranes of platelets in chronic obstructive pulmonary disease.
Objective: to study the composition of fatty acids (FA) and mitochondrial membrane potential (MMР) of blood cells in patients with chronic bronchitis (CB) and chronic obstructive pulmonary disease (COPD); to establish the role of the Mitochondrial dysfunction in the formation of respiratory diseases. Material and methods. The study involved 26 patients with chronic bronchitis, 27 - with mild COPD, 21 - with moderate COPD steady flow, 29 healthy people. MMР leukocytes was assessed by flow cytometry. The composition of the FA mitochondrial membranes was studied by gas-liquid chromatography. Results and discussion. With the worsening of the disease (moderate COPD) increases the number of white blood cells with reduced MMP, appears deficit of the saturated, monoenic (14: 0, 16: 0, 18: 0) and n-3 polyunsaturated fatty acids (18: 3n-3 20: 5n-3, 22: 5n-3, 22: 6n-3) in the membrane of the mitochondria. Identified imbalance in the composition of fatty acids verifies the changes in the physicochemical properties of subcellular membrane malfunction membrane transport systems, enzymes and receptors, processes of oxidative phosphorylation. Conclusion: The imbalance in the composition of the LCD mitochondrial membranes lead to the development of mitochondrial dysfunction and the formation of cell hypoxia.
- 26 September 2018
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 96 (4)
Open AccessThe fatty acid composition of the mitochondrial membranes of platelets in chronic obstructive pulmonary disease.
Objective: to study the composition of fatty acids (FA) and mitochondrial membrane potential (MMР) of blood cells in patients with chronic bronchitis (CB) and chronic obstructive pulmonary disease (COPD); to establish the role of the Mitochondrial dysfunction in the formation of respiratory diseases. Material and methods. The study involved 26 patients with chronic bronchitis, 27 - with mild COPD, 21 - with moderate COPD steady flow, 29 healthy people. MMР leukocytes was assessed by flow cytometry. The composition of the FA mitochondrial membranes was studied by gas-liquid chromatography. Results and discussion. With the worsening of the disease (moderate COPD) increases the number of white blood cells with reduced MMP, appears deficit of the saturated, monoenic (14: 0, 16: 0, 18: 0) and n-3 polyunsaturated fatty acids (18: 3n-3 20: 5n-3, 22: 5n-3, 22: 6n-3) in the membrane of the mitochondria. Identified imbalance in the composition of fatty acids verifies the changes in the physicochemical properties of subcellular membrane malfunction membrane transport systems, enzymes and receptors, processes of oxidative phosphorylation. Conclusion: The imbalance in the composition of the LCD mitochondrial membranes lead to the development of mitochondrial dysfunction and the formation of cell hypoxia.